|
|
Keywords PROSTATE CANCER, BRACHYTHERAPY, PATIENTS, CANCER, ASTRO, AMERICAN SOCIETY FOR RADIATION ONCOLOGY Description Prostate cancer patients who receive brachytherapy and remain free of disease for five years or greater are unlikely to have a recurrence at 10 years, according to a study in the July 1 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO). Newswise — Prostate cancer patients who receive brachytherapy and remain free of disease for five years or greater are unlikely to have a recurrence at 10 years, according to a study in the July 1 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO). Brachytherapy is the placement of... [read full story]
Quotes for Travel Emergency Medical Coverage Compared Online calculator provides sample premium rates for Travel Emergency Health Insurance that covers international visitors from virtually any country in the world. The travel...
A one-time Renaissance scholar, A.G. Lafley went on to transform P&G, one of America's iconic companies. Along the way, he had to find a way to convince the board and outbid the opposition for Clairol. Twice.
Greg Dawson The Last Resort Make room on your plate today for this final helping of good stuff about businesses and merchants. JANINE JOHNSON I want to tell you about Jason, the owner of The Pool Medics of Orlando, who has kept...
A flurry of Seattle biotech news kept us very busy around here right before the holiday. -The parents of Amazon.com founder Jeff Bezos made one of the largest private donations ever to the Fred Hutchinson Cancer Research Center...
